TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 26nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 29nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 30nMAssay Description:Cells were seeded onto 24-well plates at the density of 2.0×105 cells per well. The cells were incubated at 37° C., 5% CO2 overnight. After approxima...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 30nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 34nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 34nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 44nMAssay Description:Cells were seeded onto 24-well plates at the density of 2.0×105 cells per well. The cells were incubated at 37° C., 5% CO2 overnight. After approxima...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 45nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 55nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 66nMAssay Description:Cells were seeded onto 24-well plates at the density of 2.0×105 cells per well. The cells were incubated at 37° C., 5% CO2 overnight. After approxima...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 68nMAssay Description:Cells were seeded onto 24-well plates at the density of 2.0×105 cells per well. The cells were incubated at 37° C., 5% CO2 overnight. After approxima...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 85nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 89nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 110nMAssay Description:Cells were seeded onto 24-well plates at the density of 2.0×105 cells per well. The cells were incubated at 37° C., 5% CO2 overnight. After approxima...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 271nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 282nMAssay Description:Cells were seeded onto 24-well plates at the density of 2.0×105 cells per well. The cells were incubated at 37° C., 5% CO2 overnight. After approxima...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 332nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 424nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 504nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Shanghai Fochon Pharmaceutical
US Patent
Shanghai Fochon Pharmaceutical
US Patent
Affinity DataIC50: 828nMAssay Description:HEK293-URAT1 cell Lines were donated by Japan Fuji Biomedical Research Institute. Negative control cell of HEK293 (MOCK cells) which was transfected ...More data for this Ligand-Target Pair